Targeted therapy for squamous cell carcinoma of the head and neck
Joint Authors
al-Dus, Ibrahim T.
Ganti, Apar Kishor
Source
Journal of the Egyptian National Cancer Institute
Issue
Vol. 21, Issue 2 (30 Jun. 2009), pp.157-166, 10 p.
Publisher
Cairo University National Cancer Institute
Publication Date
2009-06-30
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Targeted agents have emerged as novel drugs in the oncology field based on our understanding of the biology of individual malignancies, and have had a promising impact in several tumors.
Squamous cell carcinoma of the head and neck (SCCHN) is a common disease with little progress made in survival over the past few decades.
SCCHN is characterized by overexpression of the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF), both of which appear to have a prognostic value.
Hence these receptors and their downstream pathways make attractive therapeutic targets.
This review discusses targeted therapies currently being evaluated for their role in squamous cell carcinoma of the head and neck.
American Psychological Association (APA)
al-Dus, Ibrahim T.& Ganti, Apar Kishor. 2009. Targeted therapy for squamous cell carcinoma of the head and neck. Journal of the Egyptian National Cancer Institute،Vol. 21, no. 2, pp.157-166.
https://search.emarefa.net/detail/BIM-273998
Modern Language Association (MLA)
al-Dus, Ibrahim T.& Ganti, Apar Kishor. Targeted therapy for squamous cell carcinoma of the head and neck. Journal of the Egyptian National Cancer Institute Vol. 21, no. 2 (Jun. 2009), pp.157-166.
https://search.emarefa.net/detail/BIM-273998
American Medical Association (AMA)
al-Dus, Ibrahim T.& Ganti, Apar Kishor. Targeted therapy for squamous cell carcinoma of the head and neck. Journal of the Egyptian National Cancer Institute. 2009. Vol. 21, no. 2, pp.157-166.
https://search.emarefa.net/detail/BIM-273998
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 163-166
Record ID
BIM-273998